CASI Pharmaceuticals Inc (NASDAQ:CASI)

3.85
Delayed Data
As of Feb 23
 +0.10 / +2.67%
Today’s Change
0.91
Today|||52-Week Range
4.84
+18.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.0023.7K47.7K0.00
 
 
 
Cost of Goods Sold0.007.5K6.3K0.00
 
 
 
Depreciation And Amortization17.4K48.2K68.4K66.5K
 
 
 
 
 
 
Operating ExpensesGross Income-17.4K-31.9K-26.9K-66.5K
 
 
 
 
 
General Expenses5.7M6.5M7.1M9.4M
 
 
 
 
 
Research And Development2.7M2.8M4.1M4.6M
 
 
 
 
 
Total Operating Expenses5.7M6.5M7.2M9.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.7M-6.5M-7.2M-9.4M
 
 
 
 
 
Extraordinary Credit0.0011.8K27.5K0.00
 
 
 
Extraordinary Charge0.00-19.7M0.00-6.8K
 
 
 
Interest Expense On Debt0.0028.1K82.5K33.8K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.7M-26.2M-7.2M-9.5M
 
 
 
 
 
Net Income-5.7M-26.2M-7.2M-9.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS26.1M28.6M32.4M55.9M
 
 
 
 
 
Shares To Calculate EPS Diluted26.1M28.6M32.4M55.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.22-$0.92-$0.22-$0.17
 
 
 
 
 
EPS Diluted-$0.22-$0.92-$0.22-$0.17